ConductScience.org, home

Trial · NCT04311983

Interventions to Help More Low-income Smokers Quit

NCT04311983, Not applicable, Completed, Washington University School of Medicine; results first posted 2024-10-10

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Interventions to Help More Low-income Smokers Quit. Trials, record NCT04311983. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04311983

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Interventions to Help More Low-income Smokers Quit
NCT number
NCT04311983
Status
Completed
Phases
Not applicable
Enrollment
1,973 participants, actual
Lead sponsor
Washington University School of Medicine
Conditions
Tobacco Use Cessation, Smoking Behaviors, Health Disparity
Interventions
Tobacco Quitline, Smoke Free Home
First posted
2020-03-17
Last updated
2024-10-10
Results first posted
2024-10-10

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary7day Point Prevalence for Smoking6 month follow-upPercentage of participants who have 7 day smoking abstinence
SecondaryProportion of Participants Who Accept the Tobacco Quitline ProgramBaseline and 3-month follow-up
* All participants are asked at baseline if they are interested in trying the \<STATE\> tobacco quitline. Some participants are asked this question again at the 3-month follow-up * The probability is the proportion who answer "yes". * Due to our study design, at 3-month follow-up, Tobacco Quitline plus Smoke Free Homes participants were only offered the Quitline if they had not chosen it at baseline. The proportion in the table is the number of participants who accepted the Quitline divided by number who were offered the Quitline.

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARY7day Point Prevalence for Smoking6 month follow-upParticipants were not included if they were lost to follow-up or were duplicate enrollees.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYProportion of Participants Who Accept the Tobacco Quitline ProgramBaseline and 3-month follow-up
At baseline, participants weren't included if they were duplicate entries. At 3-month follow-up, participants weren't included if they were duplicated entries or if they were lost to follow-up. Also, in Arm 2 at 3-month follow-up, if participants had chosen the quitline at baseline and did not quit, they were not re-offered the quitline; they were only offered Smoke-Free Homes. This was a planned part of the study design.
ParticipantsCOUNT_OF_PARTICIPANTS

Results by group6

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
7day Point Prevalence for SmokingTobacco Quitline Only78Participants
7day Point Prevalence for SmokingTobacco Quitline Plus Smoke Free Homes83Participants
Proportion of Participants Who Accept the Tobacco Quitline ProgramTobacco Quitline OnlyBaseline592Participants
Proportion of Participants Who Accept the Tobacco Quitline ProgramTobacco Quitline Plus Smoke Free HomesBaseline587Participants
Proportion of Participants Who Accept the Tobacco Quitline ProgramTobacco Quitline Only3-month follow-up385Participants
Proportion of Participants Who Accept the Tobacco Quitline ProgramTobacco Quitline Plus Smoke Free Homes3-month follow-up142Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDTobacco Quitline Only987
Overall StudySTARTEDTobacco Quitline Plus Smoke Free Homes986
Overall StudyCOMPLETEDTobacco Quitline Only558
Overall StudyCOMPLETEDTobacco Quitline Plus Smoke Free Homes521
Overall StudyNOT COMPLETEDTobacco Quitline Only429
Overall StudyNOT COMPLETEDTobacco Quitline Plus Smoke Free Homes465

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityTobacco Quitline Only1987
Total, all-cause mortalityTobacco Quitline Plus Smoke Free Homes0986
Total, other adverse eventsTobacco Quitline Only0987
Total, other adverse eventsTobacco Quitline Plus Smoke Free Homes0986
Total, serious adverse eventsTobacco Quitline Only0987
Total, serious adverse eventsTobacco Quitline Plus Smoke Free Homes0986

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
37080354DERIVEDPubMed
40018164DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01CA235773Expanding population-level interventions to help more low-income smokers quitKREUTER, MATTHEW W.; MCQUEEN, AMYWASHINGTON UNIVERSITYNATIONAL CANCER INSTITUTE2019 to 2023

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Tobacco Quitline Only vs Tobacco Quitline Plus Smoke Free Homes: 7day Point Prevalence for SmokingTrial comparisons
Tobacco Quitline Only vs Tobacco Quitline Plus Smoke Free Homes: deaths from any causeTrial comparisons
Tobacco Quitline Only vs Tobacco Quitline Plus Smoke Free Homes: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04311983

GET https://conductscience.org/api/trials/v1/NCT04311983/registered